Category: Latest News
-
Chinese Consumers Report Scratches on Apple’s New iPhone 17 Models
Apple’s (NASDAQ:AAPL) latest iPhone 17 series is facing early criticism in China, where buyers have taken to social media to complain that the devices are easily scratched. On Friday, numerous shoppers posted images online showing visible marks on the back of their new iPhones, in some cases just hours after purchase. Reports from Apple stores…
-
U.S. Stocks See Further Upside, Reach New Record Highs
Stocks moved mostly higher during trading on Friday, adding to the gains posted during Thursday’s session. With the continued upward move, the major averages all reached new record closing highs. The major averages reached new highs late in the session before giving back some ground going into the close. The Nasdaq advanced 160.75 points or…
-
Cruise line shares slide amid rising concerns over promotional activity
Shares of major cruise operators dropped on Friday as investors reacted to growing signs of increased promotional efforts across the sector. Carnival Corporation (NYSE:CCL) led the decline with a 3.2% fall, while Royal Caribbean Cruises (NYSE:RCL) lost 2.7%, Norwegian Cruise Line Holdings (NYSE:NCLH) fell 1.7%, and Viking Holdings (NYSE:VIK) slid 2.5%. The selloff comes after…
-
WeRide shares climb after obtaining Belgium’s first Level 4 autonomous shuttle permit
WeRide Corp ADR (NASDAQ:WRD) saw its stock rise 3.7% in premarket trading Friday after the autonomous vehicle company revealed that its Robobus has received Belgium’s first federal test permit for a Level 4 autonomous shuttle. The permit authorizes the Robobus to conduct tests on public roads along an 8-kilometer loop in Leuven-Heverlee, featuring nine stops.…
-
22nd Century Group shares surge after clearing remaining debt
22nd Century Group Inc (NASDAQ:XXII) saw its stock jump 14.8% in premarket trading Friday after the company confirmed it has fully repaid the remaining $3.9 million of senior secured debt. The repayment follows the completion of the company’s Series A convertible preferred stock offering, which helped eliminate one of the final legacy obligations from its…
-
Chijet Motor shares surge after naming COO to head crypto initiative
Chijet Motor Company, Inc. (NASDAQ:CJET) saw its stock jump 80% in premarket trading Friday after announcing the appointment of Jason Miller as Chief Operating Officer, tasked with leading the company’s expansion into digital currencies. Miller will oversee Chijet’s strategy to integrate leading cryptocurrencies, including Bitcoin, Ethereum, and Solana, into the company’s treasury. With more than…
-
Fathom Holdings shares drop sharply after public offering priced
Fathom Holdings Inc (NASDAQ:FTHM) saw its stock fall 14.6% in premarket trading Friday following the announcement of an underwritten public offering. The company plans to sell 3 million shares of common stock at $2.00 per share. Fathom expects to raise approximately $5.4 million in net proceeds after underwriting fees and expected expenses. The underwriter, Roth…
-
Reviva Pharmaceuticals shares tumble after $9M public offering priced
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) saw its stock dive 39% in premarket trading Friday, following the announcement of a public offering intended to raise roughly $9 million. The company plans to offer 27 million shares of common stock, or equivalents, at $0.335 per share, each paired with one Series E and one Series F warrant,…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures Signal Slight Gains Ahead
U.S. stock futures suggest a modestly higher open on Friday, as investors look to continue the momentum from Thursday’s strong session. Despite September typically being one of the weaker months for equities, major indexes have trended upward over the past few weeks. Optimism surrounding lower interest rates has bolstered the markets, following the Federal Reserve’s…
-
ARS Pharmaceuticals stock rises after Japan approves needle-free epinephrine spray
Shares of ARS Pharmaceuticals Inc. (NASDAQ:SPRY) climbed 7% on Friday following regulatory approval in Japan for the company’s needle-free epinephrine nasal spray, neffy, intended for emergency treatment of severe allergic reactions. Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) authorized neffy in 1 mg and 2 mg doses for adults and children over 15 kilograms, making…